IRIS
GATTEI, VALTER
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 819
NA - Nord America 677
AS - Asia 521
SA - Sud America 70
AF - Africa 19
OC - Oceania 2
Totale 2.108
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 642
RU - Federazione Russa 248
SG - Singapore 177
IT - Italia 165
IE - Irlanda 111
CN - Cina 86
DE - Germania 73
SE - Svezia 64
VN - Vietnam 60
BR - Brasile 59
HK - Hong Kong 59
BD - Bangladesh 48
FR - Francia 43
IN - India 40
GB - Regno Unito 29
UA - Ucraina 22
CA - Canada 20
PL - Polonia 18
FI - Finlandia 10
MX - Messico 10
KR - Corea 8
LT - Lituania 7
AT - Austria 6
BJ - Benin 6
JP - Giappone 6
TR - Turchia 6
AR - Argentina 5
ID - Indonesia 5
ZA - Sudafrica 5
CZ - Repubblica Ceca 4
IQ - Iraq 4
NL - Olanda 4
UZ - Uzbekistan 4
EG - Egitto 3
ES - Italia 3
GR - Grecia 3
HR - Croazia 3
KE - Kenya 3
PK - Pakistan 3
CH - Svizzera 2
CO - Colombia 2
JM - Giamaica 2
KG - Kirghizistan 2
MY - Malesia 2
OM - Oman 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BE - Belgio 1
BG - Bulgaria 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
GE - Georgia 1
IL - Israele 1
JO - Giordania 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
TN - Tunisia 1
TO - Tonga 1
TW - Taiwan 1
ZM - Zambia 1
Totale 2.108
Salva come PNG Salva come JPEG
Città #
Dublin 110
San Jose 100
Ashburn 63
Singapore 63
Hong Kong 58
Jacksonville 41
Beijing 38
Los Angeles 28
Moscow 24
Lauterbourg 23
Ho Chi Minh City 22
Novara 20
Council Bluffs 18
New York 18
St Louis 18
Warsaw 17
Milan 16
Boardman 15
Piemonte 15
Vercelli 15
Lawrence 14
Princeton 14
São Paulo 14
Chandler 12
Dearborn 12
Munich 11
Atlanta 9
Buffalo 9
Hanoi 9
Tornaco 9
Turin 9
Bremen 8
Denver 8
Falkenstein 8
Helsinki 8
Montreal 8
Orem 8
Santa Clara 8
Seoul 8
Frankfurt am Main 7
Mexico City 7
Podenzano 7
Redondo Beach 7
Chennai 6
Cotonou 6
London 6
Manchester 6
Belo Horizonte 5
Columbus 5
Hillsboro 5
Roseto degli Abruzzi 5
Tokyo 5
Wilmington 5
Ann Arbor 4
Boston 4
Chicago 4
Da Nang 4
Dallas 4
Hangzhou 4
Nuremberg 4
Rome 4
Seattle 4
Somaglia 4
Stockholm 4
Toronto 4
Ankara 3
Athens 3
Brno 3
Brooklyn 3
City of London 3
Grafing 3
Gunzenhausen 3
Istanbul 3
Jackson 3
Johannesburg 3
Palermo 3
Poplar 3
San Mateo 3
Sorocaba 3
Tashkent 3
Vilnius 3
Amsterdam 2
Cagliari 2
Cologno Monzese 2
Hackney 2
Houston 2
Jakarta 2
Kingston 2
Lewisham 2
Mosul 2
Norwalk 2
Piscataway 2
Rimini 2
Rio de Janeiro 2
Roubaix 2
San Francisco 2
Santana do Araguaia 2
Suzano 2
Thái Bình 2
Turku 2
Totale 1.124
Salva come PNG Salva come JPEG
Nome #
Molecular clustering on ctDNA improves the prognostic stratification of DLBCL patients compared to ctDNA levels 175
Immunoglobulin light chain mutational status refines IGHV prognostic value in identifying chronic lymphocytic leukemia patients with early treatment requirement 138
A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the "Fondazione Italiana Linfomi" MCL-0208 trial 129
Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia 106
Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study 106
HIF-1α is overexpressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia 104
Mutations in the 3′ untranslated region of NOTCH1 are associated with low CD20 expression levels in chronic lymphocytic leukemia 102
CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression 102
NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: link between the NOTCH1 and the NF-κB pathways 93
XPO1 mutations identify early‐stage CLL characterized by shorter time to first treatment and enhanced BCR signalling 91
Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study 91
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases 89
Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials 87
Local radiotherapy and measurable residual disease-driven immunotherapy in patients with early-stage follicular lymphoma (FIL MIRO): final results of a prospective, multicentre, phase 2 trial 85
Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib–rituximab 83
TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases 81
Quality assessment for PCR-based minimal residual disease in Lymphoma: 10 Years of cross-laboratory standardization process within the fondazione italiana linfomi MRD network 76
Integration of [18F]FDG-PET radiomics with liquid biopsy improves outcome prediction in newly diagnosed diffuse large B-cell lymphoma 74
Elastin MIcrofibriL INterfacer1 (EMILIN-1) is an alternative prosurvival VLA-4 ligand in chronic lymphocytic leukemia 74
CD49d expression is included in a revised 4‐factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real‐world experience 62
Efficacy of front‐line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter “Real‐World” study 50
The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligands 49
A comprehensive genetic study of classic Hodgkin lymphoma using circulating tumor DNA 48
Dissecting clonal hematopoiesis in the myeloid compartment of chronic lymphocytic leukemia and Richter transformation 32
Clinical Frailty Scale as a Predictor of Early Treatment Discontinuation in Elderly Patients With Chronic Lymphocytic Leukemia Treated With Zanubrutinib: A Multicenter Real-World Study 13
No lymphocytosis increase after cBTKi is a rare phenomenon except for CD49d positive CLL mainly expressed in trisomy 12 3
CD49d governs immune synapse formation through actin rearrangements and synchronizes BCR signaling in CLL 2
Totale 2.145
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.395
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.395
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202257 0 0 3 4 5 0 3 0 4 2 14 22
2022/2023212 15 13 17 0 10 15 7 15 109 1 3 7
2023/2024106 8 13 9 6 13 1 16 0 0 0 10 30
2024/2025328 7 0 9 2 11 14 41 79 66 21 14 64
2025/20261.272 51 40 53 128 173 104 154 194 95 120 127 33
Totale 2.145